Recruiting is underway for a major study called DETECT, funded by the National Institutes of Health (NIH) and led from within the Heart Center at Wake Forest Baptist Medical Center.
For DETECT, about 120 people above the age of 18 who are going through chemotherapy are being recruited. These participants will begin with free basic medical tests and their first or baseline cardiovascular MRI before chemotherapy begins. They will be monitored for 6 to 8 months and have 3 additional MRIs to determine if there is any heart damage that may be caused by the chemotherapy. Results of all of these tests for both PREDICT and DETECT participants can be sent to their primary care physicians. To find out if you are a candidate for the DETECT study, please call 336-716-7082.
Greg Hundley, MD, a professor of Cardiology, Internal Medicine, and Radiology, is the principal investigator for the study. He noted that the study is a collaborative project with Wake Forest School of Medicine and N.C. Baptist Hospital, involving the Departments of Biomedical Engineering, Hematology/Oncology, Internal Medicine, Public Health Sciences, and Radiology.